YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - Miravalles Gold Corp. (CSE: MIRA) (OTC Pink: SSRSF) (the "Company" or "Miravalles") announces the filing of an independent technical report for its Fairfield Gold Project…
(RTTNews) - MIRA Pharmaceuticals Inc. (MIRA), a clinical-stage pharmaceutical company, on Thursday reported positive toxicokinetic data for SKNY-1 to facilitate future studies as a GLP-1 drug with potential for treating obesity. SKNY-1 has…
Founded in 2018, Clockwork pioneered AI forecasting for small and medium sized businesses. Now it adds Mira, an agentic analyst that runs forecasts, builds scenarios, and explains the numbers straight from QuickBooks and Xero, putting a CF…
Key Takeaways; Cannabis Sector Aurora Cannabis Announced Refocused Strategy as Global Medical Sales Hit Record High in 2026 Third Quarter Canopy Growth Reported Mixed Results in its Fiscal Third Quarter of 2026 Cronos Group Launched Premiu…
Key Takeaways; Cannabis Sector Verano Holdings Ended Legal Battle with Vireo Growth; The Company Also Reported Third Quarter 2025 Financial Results Jushi Holdings’ Subsidiary is Targeting DoorDash and Total Wine in Landmark Lawsuit Over Il…
Health care stocks fell late Thursday afternoon with the NYSE Health Care Index down 0.2% and the He PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. [postmarket] GAINERS TICKER CHANGE COMMENT WBTN [https://www.chartmill.com/stock/quote/WBTN/profile] 71.66% After the regular…
New York, USA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Cannabinoids are specific chemical compounds found in cannabis,…
MIAMI - MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a $20.3 million market cap biotech company, announced new preclinical results for its obesity and nicotine addiction drug candidate SKNY-1, showing the compound reversed anxiety-related beh…
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a pharmaceutical company with a market capitalization of $19.46 million, announced Monday that it sold 1,550,741 shares of its common stock to an institutional investor through block sales as part…
FiEE (MINM) shares were up 37% in recent Thursday premarket activity, after the company said Wednesd PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Key Takeaways; Cannabis Sector MediPharm pushed back against Apollo’s boardroom challenge Organigram was named “Exporter of the Year” for cannabis innovation and global reach Green Thumb posted solid Q1 2025 results, as the company focuses…
In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on earnings, a patent grant and study results. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-so…
Mira Pharmaceuticals, Inc.’s (NASDAQ:MIRA) Board of Directors unanimously approved on Thursday the planned acquisition of SKNY Pharmaceuticals, Inc., following the completion of independent valuation reports on both companies. In March, MI…
EXCLUSIVE: MIRA Pharmaceuticals Signs To Acquire SKNY Pharmaceuticals, Expand Pipeline Into Weight Loss And Smoking Cessation Drug On Monday, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) signed a binding letter of intent (LOI) to acquire SKNY…